Jean-christophe Lemarie
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 26, 2022
Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study.
Journal: Frontiers in pediatrics
Published: March 16, 2021
Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: November 04, 2014
Validation of two predictive models for survival in pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: January 06, 2014
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis.
Journal: PLoS medicine
Published: December 19, 2013
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.
Journal: International journal of cardiology
Published: May 29, 2013
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
Journal: American heart journal
Published: November 23, 2012
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
Journal: American heart journal
Published: November 23, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026